Melatonin for Prevention of Delirium in Critically Ill Patients
Status:
Unknown status
Trial end date:
2019-10-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the feasibility of conducting a randomized
controlled trial (RCT) with melatonin for prevention of delirium in critically ill adult
patients. The investigators hypothesize that melatonin, administered on a scheduled nightly
basis during ICU admission, will be efficacious and safe for the prevention of delirium in
critically ill adults.
Phase:
Phase 2
Details
Lead Sponsor:
Mount Sinai Hospital, Canada
Collaborators:
Hopital du Sacre-Coeur de Montreal Sunnybrook Health Sciences Centre